Articles with public access mandates - Michael A. Tainsky, PhDLearn more
Available somewhere: 28
Critical pathways in cellular senescence and immortalization revealed by gene expression profiling
AL Fridman, MA Tainsky
Oncogene 27 (46), 5975-5987, 2008
Mandates: US National Institutes of Health
Genomic and proteomic biomarkers for cancer: a multitude of opportunities
MA Tainsky
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1796 (2), 176-193, 2009
Mandates: US National Institutes of Health
Gene expression profiling of replicative and induced senescence
M Purcell, A Kruger, MA Tainsky
Cell Cycle 13 (24), 3927-3937, 2014
Mandates: US National Institutes of Health
Epigenetic silencing of IRF7 and/or IRF5 in lung cancer cells leads to increased sensitivity to oncolytic viruses
Q Li, MA Tainsky
PloS one 6 (12), e28683, 2011
Mandates: US National Institutes of Health
Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer
S Mellon, R Gold, J Janisse, M Cichon, MA Tainsky, MS Simon, J Korczak
Psycho‐Oncology 17 (8), 756-766, 2008
Mandates: US National Institutes of Health
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study
V Balan, P Nangia-Makker, AG Schwartz, YS Jung, L Tait, V Hogan, T Raz, ...
Cancer research 68 (24), 10045-10050, 2008
Mandates: US National Institutes of Health
Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts
Q Li, L Tang, PC Roberts, JM Kraniak, AL Fridman, OI Kulaeva, ...
Molecular Cancer Research 6 (5), 770-784, 2008
Mandates: US National Institutes of Health
Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area
X Wang, AM Levin, SE Smolinski, FD Vigneau, NK Levin, MA Tainsky
American Journal of Medical Genetics Part A 158 (12), 3061-3064, 2012
Mandates: US National Institutes of Health
Telomere dysfunction and chromothripsis
A Ernst, DTW Jones, KK Maass, A Rode, KI Deeg, BMC Jebaraj, ...
International journal of cancer 138 (12), 2905-2914, 2016
Mandates: German Research Foundation
Usage of cancer associated autoantibodies in the detection of disease
SP Dudas, M Chatterjee, MA Tainsky
Cancer Biomarkers 6 (5-6), 257-270, 2010
Mandates: US National Institutes of Health
CREG1 enhances p16INK4a-induced cellular senescence
B Moolmuang, MA Tainsky
Cell Cycle 10 (3), 518-530, 2011
Mandates: US National Institutes of Health
Analysis of the expression of human tumor antigens in ovarian cancer tissues
R Ali-Fehmi, M Chatterjee, A Ionan, NK Levin, H Arabi, S Bandyopadhyay, ...
Cancer Biomarkers 6 (1), 33-48, 2010
Mandates: US National Institutes of Health
Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput
M Chatterjee, J Wojciechowski, MA Tainsky
Tumor Biomarker Discovery: Methods and Protocols, 21-38, 2009
Mandates: US National Institutes of Health
Predictors of decision making in families at risk for inherited breast/ovarian cancer.
S Mellon, J Janisse, R Gold, M Cichon, L Berry-Bobovski, MA Tainsky, ...
Health Psychology 28 (1), 38, 2009
Mandates: US National Institutes of Health
Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer
M Chatterjee, LC Hurley, MA Tainsky
Gynecologic oncology reports 21, 37-44, 2017
Mandates: US National Institutes of Health
Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53
LC Hurley, NK Levin, M Chatterjee, J Coles, S Muszkat, Z Howarth, ...
Cancer Biomarkers 27 (3), 407-421, 2020
Mandates: US National Institutes of Health
Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer
X Wang, JK Teer, RN Tousignant, AM Levin, D Boulware, DA Chitale, ...
Genes, Chromosomes and Cancer 57 (1), 19-27, 2018
Mandates: US Department of Defense, US National Institutes of Health
Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033
JT Dilworth, JW Wojtkowiak, P Mathieu, MA Tainsky, JJ Reiners Jr, ...
Cancer biology & therapy 7 (12), 1938-1946, 2008
Mandates: US National Institutes of Health
Autoantibodies as biomarkers for ovarian cancer
M Chatterjee, MA Tainsky
Cancer Biomarkers 8 (4-5), 187-201, 2011
Mandates: US National Institutes of Health
The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors
JM Kraniak, D Sun, RR Mattingly, JJ Reiners, MA Tainsky
Molecular and cellular biochemistry 344, 267-276, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program